Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.93% | 246.08 | 1.3% | $803.28m | |
| IMMU | Immunomedics, Inc. | 0.06% | 85.41 | 11.0% | $697.59m | |
| MRNA | Moderna, Inc. | 1.93% | 70.81 | 0.0% | $679.34m | |
| NVAX | Novavax, Inc. | -3.41% | 109.69 | 96.5% | $607.57m | |
| ILMN | Illumina, Inc. | 1.09% | 303.16 | 3.5% | $589.15m | |
| GILD | Gilead Sciences, Inc. | 0.82% | 62.76 | 1.0% | $578.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.62% | 564.77 | 2.7% | $436.21m | |
| BIIB | Biogen, Inc. | 2.87% | 281.11 | 1.6% | $344.57m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.24% | 267.53 | 1.9% | $340.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.83% | 113.48 | 2.0% | $282.85m | |
| EXAS | EXACT Sciences Corp. | 3.25% | 100.87 | 20.7% | $265.64m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.69% | 10.28 | 1.5% | $256.99m | |
| SGEN | Seattle Genetics, Inc. | 2.33% | 189.25 | 6.0% | $217.07m | |
| VXRT | Vaxart, Inc. | -4.60% | 7.06 | 0.0% | $204.06m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.09% | 52.45 | 3.0% | $193.77m |
Company Profile
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.